Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Inotiv
(NASDAQ:NOTV)
Intraday
$4.31
-0.36
[-7.71%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$4.31
-0.36
[-7.71%]
Last update: 3:35PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Inotiv Stock (NASDAQ:NOTV)
Inotiv Stock (NASDAQ: NOTV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 04, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Apr 4, 2024, 12:31PM
Friday, February 09, 2024
CyberArk Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
-
Feb 9, 2024, 8:11AM
Jefferies Upgrades Inotiv to Buy, Raises Price Target to $11.5
Benzinga Newsdesk
-
Feb 9, 2024, 5:29AM
Wednesday, February 07, 2024
Inotiv Reaffirms FY24 Revenues To Be $580M-$590M, Est $578.14M
Benzinga Newsdesk
-
Feb 7, 2024, 5:14PM
Inotiv: Q1 Earnings Insights
Benzinga Insights
-
Feb 7, 2024, 4:45PM
Inotiv Q1 2024 GAAP EPS $(0.60) Beats $(0.85) Estimate, Sales $135.50M Beat $132.86M Estimate
Benzinga Newsdesk
-
Feb 7, 2024, 4:44PM
Earnings Scheduled For February 7, 2024
Benzinga Insights
-
Feb 7, 2024, 5:13AM
Tuesday, February 06, 2024
A Preview Of Inotiv's Earnings
Benzinga Insights
-
Feb 6, 2024, 2:02PM
Tuesday, December 12, 2023
Craig-Hallum Maintains Buy on Inotiv, Lowers Price Target to $25
Benzinga Newsdesk
-
Dec 12, 2023, 10:42AM
Monday, December 11, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Dec 11, 2023, 4:31PM
Inotiv: Q4 Earnings Insights
Benzinga Insights
-
Dec 11, 2023, 4:15PM
Inotiv Expects FY24 Revenues Of $580M-$590M, Estimate $582.65M
Benzinga Newsdesk
-
Dec 11, 2023, 4:10PM
Inotiv Q4 EPS $(0.38), Sales $140.74M Beat $139.43M Estimate
Benzinga Newsdesk
-
Dec 11, 2023, 4:08PM
Earnings Scheduled For December 11, 2023
Benzinga Insights
-
Dec 11, 2023, 4:52AM
Friday, December 08, 2023
Inotiv's Earnings Outlook
Benzinga Insights
-
Dec 8, 2023, 9:00AM
Wednesday, December 06, 2023
Inotiv Plans Taking Direct Control Of Its Transportation Operations; Will Be Partnering With Vanguard Supply Chain Solutions To Enable The In-house Integration
Benzinga Newsdesk
-
Dec 6, 2023, 4:36PM
Monday, October 16, 2023
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 16, 2023, 1:09PM
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 21, 2023, 12:08PM
Wednesday, August 30, 2023
Inotiv Completes Sale Of Israeli Businesses To Harlan Holdings As Part Of Strategic Optimization Plan
Benzinga Newsdesk
-
Aug 30, 2023, 1:39AM
Tuesday, August 15, 2023
'Inotiv Faces SEC Probe On Imports Of Monkeys From Asia' - WSJ
Benzinga Newsdesk
-
Aug 15, 2023, 3:39PM
Friday, August 11, 2023
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Aug 11, 2023, 1:47PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Aug 11, 2023, 1:31PM
Inotiv shares are trading lower after the company announced Q3 revenue results and issued FY23 revenue guidance below estimates.
Benzinga Newsdesk
-
Aug 11, 2023, 10:53AM
Inotiv On Thursday Reported Q3 EPS $0.07 Beats $(0.10) Estimate, Sales $157.47M Beat $151.08M Estimate
Benzinga Newsdesk
-
Aug 11, 2023, 10:48AM
Thursday, August 10, 2023
Inotiv Sees FY23 Revenue $570M, Down From Previous Guidance Of $580M Vs 580.93M Est.
Happy Mohamed
-
Aug 10, 2023, 4:24PM
Earnings Scheduled For August 10, 2023
Benzinga Insights
-
Aug 10, 2023, 6:59AM
Thursday, July 20, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jul 20, 2023, 1:30PM
Inotiv shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight Rating, and a price target of $9.
Benzinga Newsdesk
-
Jul 20, 2023, 11:28AM
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023
Benzinga Insights
-
Jul 20, 2023, 11:00AM
Wells Fargo Initiates Coverage On Inotiv with Overweight Rating, Announces Price Target of $9
Benzinga Newsdesk
-
Jul 20, 2023, 6:57AM
Thursday, June 22, 2023
Inotiv Option Alert: Aug 18 $5 Calls Sweep (29) near the Ask: 666 @ $1.25 vs 0 OI; Earnings 8/9 After Close [est] Ref=$4.96
Charles Gross
-
Jun 22, 2023, 11:35AM
Thursday, May 11, 2023
Inotiv: Q2 Earnings Insights
Benzinga Insights
-
May 11, 2023, 5:10PM
Inotiv Q2 EPS $(0.39) Beats $(0.42) Estimate, Sales $151.46M Beat $133.29M Estimate
Happy Mohamed
-
May 11, 2023, 4:08PM
Earnings Scheduled For May 11, 2023
Benzinga Insights
-
May 11, 2023, 9:58AM
Thursday, May 04, 2023
Inotiv, Inc. Expands Safety Pharmacology Offering To Include Cardiopulmonary Telemetry
Happy Mohamed
-
May 4, 2023, 8:39AM
Thursday, March 09, 2023
Reuters Reported U.S. Justice Dept Scrutinizing USDA Failure To Sanction Beagle Breeder Envigo, Citing Sources
Charles Gross
-
Mar 9, 2023, 6:08AM
Tuesday, February 14, 2023
Inotiv Sees FY23 Revenue Of At Least $580M Vs $576.72M Est.; $75M Of Adjusted EBITDA
Happy Mohamed
-
Feb 14, 2023, 12:38AM
Inotiv Q1 EPS $(0.82) Beats $(1.30) Estimate, Sales $122.75M Beat $118.75M Estimate
Happy Mohamed
-
Feb 14, 2023, 12:35AM
Monday, February 13, 2023
Earnings Scheduled For February 13, 2023
Benzinga Insights
-
Feb 13, 2023, 7:44AM
Thursday, January 19, 2023
Inotiv shares are trading lower after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $10 to $8.
Michael Horton
-
Jan 19, 2023, 12:39PM
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
Benzinga Insights
-
Jan 19, 2023, 10:01AM
Jefferies Downgrades Inotiv to Hold, Lowers Price Target to $8
Benzinga Newsdesk
-
Jan 19, 2023, 5:07AM
Wednesday, January 11, 2023
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Jan 11, 2023, 1:15PM
Why Inotiv Shares Are Shooting Higher Today
Adam Eckert
-
Jan 11, 2023, 10:52AM
US Stocks Open Higher; Nasdaq Rises 60 Points
Lisa Levin
-
Jan 11, 2023, 10:03AM
Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023
Benzinga Insights
-
Jan 11, 2023, 10:01AM
Inotiv shares are trading higher after the company reported better-than-expected Q4 EPS results.
Benzinga Newsdesk
-
Jan 11, 2023, 9:32AM
Lake Street Upgrades Inotiv to Buy, Raises Price Target to $10
Benzinga Newsdesk
-
Jan 11, 2023, 9:13AM
Tuesday, January 10, 2023
Inotiv Q4 Adj. EPS $(0.32) Beats $(0.37) Estimate
Michael Horton
-
Jan 10, 2023, 5:40PM
Inotiv Q4 Adj. EPS $(0.32) Beats $(0.37) Estimate, Sales $150.45M Miss $152.96M Estimate
Benzinga Newsdesk
-
Jan 10, 2023, 4:07PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch